Home › Funds › Saturn V Capital Management LP › SGMT

Saturn V Capital Management LP position in SGMT

SAGIMET BIOSCIENCES INC · Health Care

Saturn V Capital Management LP reported holding 2,002,813 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$19.8M, representing 2.90% of its reported portfolio and ranking #15 among its reported holdings. Saturn V Capital Management LP has disclosed SGMT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.00M sh
Reported value held$19.79M
Portfolio Weight2.90%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's SGMT position evolved

Saturn V Capital Management LP first disclosed a stake in SGMT in Q2 2026 at 1,479,918 shares (US$11.4M). The position peaked in Q3 2026 at 2,002,813 shares, worth US$19.8M. Across 2 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,002,813 shares valued at US$19.8M — an increase of 522,895 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.48M $11.44M New
Q3 2026 2.00M $19.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGMT and 13F data

SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), Affinity Asset Advisors, LLC (US$25.0M), BVF INC/IL (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGMT

All SGMT fund holders →

FAQ

How long has Saturn V Capital Management LP held SGMT?

Saturn V Capital Management LP has disclosed SGMT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Saturn V Capital Management LP's current position in SGMT?

As of Q3 2026, Saturn V Capital Management LP holds 2.00M shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $19.79M, representing 2.90% of its reported portfolio and ranking #15.

Has Saturn V Capital Management LP been buying or selling SGMT?

In the latest 13F filing (Q3 2026), Saturn V Capital Management LP increased its position in SGMT. The position peaked in Q3 2026 at 2.00M shares.

Which other funds hold SGMT?

Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, Affinity Asset Advisors, LLC, BVF INC/IL, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.